首页> 外国专利> Endothelial Facilitation in Neurodegerative Diseases by Cerebral Blood Flow Enhancement

Endothelial Facilitation in Neurodegerative Diseases by Cerebral Blood Flow Enhancement

机译:通过脑血流量增强促进神经退行性疾病中的内皮细胞

摘要

The “amyloid hypothesis” has dominated Alzheimer research for more than 20 years, and proposes that amyloid is the toxic cause of neural/synaptic damage and dementia. Despite discrepancies in the proposed mechanism, and failed clinical trials, amyloid continues to be considered the cause of a degenerative cascade. The present invention proposes that AD is precipitated by impaired microvascular function, resulting primarily from decreased Notch-related angiogenesis. With impaired microvasculature, a lack of vascular endothelial-derived trophic factors and decreased cerebral blood flow cause the atrophy of neural structures. Therapeutic strategies are proposed that focus on supporting normal angiogenesis.
机译:“淀粉样假说”在阿尔茨海默氏症研究中占主导地位已有20多年了,并提出淀粉样蛋白是神经/突触损伤和痴呆的毒性原因。尽管提出的机制存在差异,并且临床试验失败,但淀粉样蛋白仍被认为是变性级联的原因。本发明提出AD通过微血管功能受损而沉淀,这主要是由于Notch相关的血管生成减少所致。微血管受损,缺乏血管内皮源营养因子和脑血流量减少会导致神经结构萎缩。提出了集中于支持正常血管生成的治疗策略。

著录项

  • 公开/公告号US2020253976A1

    专利类型

  • 公开/公告日2020-08-13

    原文格式PDF

  • 申请/专利权人 UNIVERSITY OF MASSACHUSETTS;

    申请/专利号US201816651570

  • 发明设计人 DAVID DRACHMAN;

    申请日2018-09-28

  • 分类号A61K31/519;A61K31/155;A61K31/17;A61K31/40;A61K31/405;A61K31/366;A61K31/47;A61K31/25;A61K31/505;A61P25/28;A61K45/06;

  • 国家 US

  • 入库时间 2022-08-21 11:27:04

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号